Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Locus Cell CoROCO:6891 -2.89%22 PS Ratio is 613.49 as of Aug. 13, 2026, which is 94% below its 10-year median of 10,629.17. GuruFocus rates ROCO:6891 with a GF Score™ of 22/100 and a GF Value™ of NT$778.63 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 931 Biotechnology companies, Locus Cell Co ranks worse than 94.41% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Locus Cell Co's share price is NT$38.65.
Locus Cell Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was NT$0.06. Hence, Locus Cell Co's PS Ratio for today is 613.49.
The historical rank and industry rank for Locus Cell Co's PS Ratio or its related term are showing as below:
ROCO:6891'
s PS Ratio Range Over the Past 10 Years
Min: 375 Med: 10629.17 Max: 16750
Current: 613.5
During the past 6 years, Locus Cell Co's highest PS Ratio was 16750.00. The lowest was 375.00. And the median was 10629.17.
ROCO:6891's PS Ratio is ranked worse than 94.41% of 931
companies
in the Biotechnology industry
Industry Median: 9.58
vs ROCO:6891: 613.50
During the past 12 months, the average Revenue per Share Growth Rate of Locus Cell Co was 433.30% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 177.30% per year.
During the past 6 years, Locus Cell Co's highest 3-Year average Revenue per Share Growth Rate was 177.30% per year. The lowest was 177.30% per year. And the median was 177.30% per year.
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Locus Cell Co PS Ratio Related Terms
Locus Cell Co PS Ratio Historical Data
* Premium members only.
The historical data trend for Locus Cell Co's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6891 vs VRTX, REGN, RVMD: PS Ratio Comparison
For the Biotechnology subindustry, Locus Cell Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Locus Cell Co PS Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Locus Cell Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where Locus Cell Co's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Locus Cell Co's Share Price of today is NT$38.65.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Locus Cell Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was NT$0.06.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Locus Cell Co (ROCO:6891) has a PS Ratio of 613.49 as of Aug. 13, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Locus Cell Co and its competitors. This is 94% below median its historical median of 10,629.17. Over the past decade, Locus Cell Co's PS Ratio has ranged from 375.00 to 16,750.00. According to the industry distribution chart, Locus Cell Co ranks #879 out of 931 companies in the Biotechnology industry, placing it in the top 94.4%.
Is Locus Cell Co's PS Ratio too high?
Locus Cell Co's current PS Ratio of 613.49 is 94% below median its 10-year median of 10,629.17. Over the past 10 years, this metric has ranged from a low of 375.00 to a high of 16,750.00. The Biotechnology industry median PS Ratio is 9.58. Locus Cell Co's value of 613.49 is 6303.9% above this industry median. Based on the distribution chart, Locus Cell Co ranks #879 out of 931 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Locus Cell Co has a GF Score™ of 22/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Locus Cell Co's PS Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Locus Cell Co ranks #879 out of 931 companies for PS Ratio. This places Locus Cell Co in the lower half of its industry. The industry median PS Ratio is 9.58. Locus Cell Co's value of 613.49 is 6303.9% above this benchmark. Historically, Locus Cell Co's own PS Ratio has ranged from 375.00 to 16,750.00 over the past decade. While the company's 10-year median is 10,629.17 vs. the industry median of 9.58, Locus Cell Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Biotechnology company?
The median PS Ratio among Biotechnology companies is 9.58, based on 931 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Locus Cell Co's current PS Ratio of 613.49 is 6303.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Locus Cell Co and its competitors. For the Biotechnology industry, the median PS Ratio is 9.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Locus Cell Co's current PS Ratio is 613.49, which is 94% below median its own 10-year median of 10,629.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Locus Cell Co stock overvalued right now?
Based on GuruFocus' analysis, Locus Cell Co (ROCO:6891) is currently considered Possible Value Trap. The stock's GF Value™ is NT$778.63, compared to a current price of NT$38.65 — trading 95% below its estimated fair value. The current PS Ratio is 613.49, which is 94% below median its 10-year median of 10,629.17 and 6303.9% above the Biotechnology industry median of 9.58. Locus Cell Co's overall GF Score™ is 22/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Locus Cell Co (ROCO:6891), the current PS Ratio is 613.49 as of Aug. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Locus Cell Co (ROCO:6891) Overvalued in 2026?
Based on GuruFocus' analysis, Locus Cell Co stock appears to be undervalued.
The current stock price of NT$38.65 is trading 95% below its estimated GF Value™ of NT$778.63.
GuruFocus considers Locus Cell Co to be Possible Value Trap.
Key valuation signals for ROCO:6891:
PS Ratio: 613.49 (94% below median its 10-year median of 10,629.17)
GF Value™: NT$778.63 vs. price of NT$38.65 (95% below fair value)
Industry Position: 6303.9% above the Biotechnology median (#879 of 931)
No single metric tells the full story. See the ROCO:6891 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6891 has been successfully added to your 
